Evaluating the Effectiveness of Prognostic Models in Patients with Cardiogenic Shock Undergoing VA-ECMO Support - Takeaways - MDSpire

Evaluating the Effectiveness of Prognostic Models in Patients with Cardiogenic Shock Undergoing VA-ECMO Support

  • By

  • Maria Calvo-Barceló

  • Finn Boyhan Irvine

  • Niamh Tierney

  • Shivani Ayyar

  • Taylor Devine

  • Vasileios Panoulas

  • Maria Montegudo-Vela

  • Fernando Riesgo Gil

  • Clara Hernandez Caballero

  • I. Dolores Poveda Pinedo

  • Javier Bautista

  • Jason Van Schoor

  • Donna Hall

  • Sofia Pinto

  • Eftychia Galiatsou

  • Alex Rosenberg

  • April 28, 2026

  • 0 min

Share

  • 1

    Existing prognostic scores for patients undergoing VA-ECMO for cardiogenic shock show poor discrimination and limited clinical utility.

  • 2

    In a study of 265 VA-ECMO runs, survival rates were 52% to decannulation, 41% to ICU discharge, and 37% to six months.

  • 3

    The SAVE, Alfred, and PREDICT 6 h scores were the only models that significantly differed between survivors and non-survivors.

  • 4

    Aetiology of cardiogenic shock emerged as the only independent predictor of survival, with myocarditis showing the highest survival rate.

  • 5

    Future prognostic models should integrate aetiology and other readily available variables to enhance decision-making for VA-ECMO.

Original Source(s)

Related Content